NewsBenzingaTakeda Pharmaceutical Co eleva la guía de BPA básico para el ejercicio fiscal 2026 de JPY 472 a JPY 482; eleva la guía de ingresos para el ejercicio fiscal 2026 de JPY 4,640 mil millones a JPY 4,700 mil millones Takeda Pharmaceutical Co eleva la guía de BPA básico para el ejercicio fiscal 2026 de JPY 472 a JPY 482; eleva la guía de ingresos para el ejercicio fiscal 2026 de JPY 4,640 mil millones a JPY 4,700 mil millones Benzinga 2026.10.29 07:57 (GMT+0) Open on Benzinga Other news Here's How Much $1000 Invested In Analog Devices 20 Years Ago Would Be Worth Today RPC Says Richard A. Hubbell To Retire As Executive Chairman And Director Effective Dec 31, 2026 Neocloud Stocks Catch a Bid After Nvidia Q3 Beat NVIDIA Interim CEO Says Co.'s Q4 Sales Growth To Be Driven By AI Demand, Vera Rubin Rollout NVIDIA Interim CEO Says Co. Remains On Track To Launch Vera Rubin Ultra Next Year And Feynman In 2028 ReAlpha Tech Corp Q3 EPS $(0.60) Misses $(0.50) Estimate, Sales $1.604M Miss $5.644M Estimate
NVIDIA Interim CEO Says Co. Remains On Track To Launch Vera Rubin Ultra Next Year And Feynman In 2028